Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-7.08%
trims when stocks drop
when a holding falls −10%+
Middle response
+1.01%
steady accumulation
Rally response
+0.10%
adds into rallies
when a holding rises +10%+
Top positions · 8
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| PHVSPharvaris N.V. | $135M | 56.9% | +79.9% | 5.3 yr |
| CYTKCytokinetics, Incorporat | $33M | 14.0% | +64.0% | 3.5 yr |
| EIKNEikon Therapeutics, Inc. | $21M | 8.7% | — | 0.3 yr |
| LYELLyell Immunopharma, Inc. | $16M | 6.8% | — | 1.0 yr |
| RLAYRelay Therapeutics, Inc. | $10M | 4.2% | +279.8% | 2.8 yr |
| XENEXenon Pharmaceuticals In | $9M | 3.9% | +73.3% | 1.3 yr |
| ALECAlector, Inc. | $8M | 3.5% | +74.8% | 1.5 yr |
| MAZEMaze Therapeutics, Inc. | $5M | 2.0% | +171.1% | 1.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+7.8pp$237M
Country
NL56.9%-5.4pp
US39.1%+9.2pp
CA3.9%
Top 5: 90.6% · Top 10: 100.0% · Top 25: 100.0%
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 2
| EIKN Eikon Therapeutics, Inc. Commonew | +$21M |
| CYTK Cytokinetics, Incorporated | +$3M |
Top sells this quarter · 1
| MAZE Maze Therapeutics, Inc. | −$11M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $237M | 8 | +109.13% | +17.59% | +91.54% | +0.01B |
| 2025-12-31 | $230M | 7 | +71.81% | +17.72% | +54.09% | +0.01B |
| 2025-09-30 | $183M | 6 | +17.71% | +17.52% | +0.19% | -0.01B |
| 2025-06-30 | $124M | 6 | -27.76% | +14.94% | -42.70% | +0.00B |
| 2025-03-31 | $111M | 5 | -43.93% | +8.30% | -52.23% | +0.02B |
| 2024-12-31 | $109M | 4 | -32.44% | +24.89% | -57.32% | -0.02B |
| 2024-09-30 | $153M | 5 | +2.51% | +36.04% | -33.52% | +0.01B |
| 2024-06-30 | $149M | 4 | +8.60% | +24.49% | -15.89% | -0.02B |
| 2024-03-31 | $198M | 5 | +61.97% | +29.62% | +32.35% | +0.01B |
| 2023-12-31 | $198M | 5 | +20.64% | +26.18% | -5.54% | -0.03B |
| 2023-09-30 | $180M | 7 | +1.87% | +21.57% | -19.70% | -0.03B |
| 2023-06-30 | $203M | 7 | -29.74% | +19.42% | -49.16% | -0.04B |
| 2023-03-31 | $193M | 8 | -53.82% | -7.82% | -46.00% | +0.02B |
| 2022-12-31 | $234M | 8 | +7.50% | +7.56% | -0.06% | -0.10B |
| 2022-09-30 | $311M | 8 | -29.21% | -4.93% | -24.28% | +0.05B |
| 2022-06-30 | $371M | 8 | -15.78% | -16.11% | +0.33% | +0.07B |